Non-motor symptoms and gender differences in multiple system atrophy
Objective: Objective: To determine the frequency and gender differences of non-motor symptoms (NMS) in patients with multiple system atrophy (MSA). Background: Background: NMS are a…The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population
Objective: The etiology of MSA remains uncertain. Cholesterol and its metabolism derangements, α-Synuclein and CoQ2 genetic polymorphism have been disclosed to be associated with the…Hand skin temperature and its response to cooling in clinical differentiation of multiple system atrophy and Parkinson’s disease
Objective: To determine the value of testing hand temperature and its response to cooling for differential diagnosis of multiple system atrophy (MSA) versus Parkinson's disease…Unusual phenotype of pathologically confirmed progressive supranuclear palsy with autonomic dysfunction and cerebellar ataxia
Objective: To report two cases of patients with unusual manifestation of pathologically confirmed PSP. Background: Based on the results of recent multicenter clinical-pathological studies, it…Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review
Objective: To systematically review the literature for evidence of an association between orthostatic hypotension (OH) and cognitive impairment (CI) in α-synucleinopathies and to discuss possible…The Catalan multiple system atrophy-registry (CMSAR)
Objective: To collect comprehensive and standardized clinical data and to create a repository of biological samples and cell lines from probable and possible MSA patients…Cognitive impairment in patients with progressive supranuclear palsy and multiple system atrophy
Objective: Assessment, description and mutual comparison of cognitive impairment in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Background: In most recent…Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease
Objective: We aimed to directly compare middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) value of the putamen and cerebellum, and 123I-metaiodobenzylguanidine (MIBG) myocardial…Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism
Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry
Objective: We previously reported that voxel-based morphometry (VBM) is effective for classifying the disease types causing cerebellar atrophy. In the present study, with the objective…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- 20
- Next Page »